Netarsudil is a Rho kinase inhibitor used as an ophthalmic medication to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Laboratories rely on a comprehensive range… Read more



































Netarsudil is a Rho kinase inhibitor used as an ophthalmic medication to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Laboratories rely on a comprehensive range of Netarsudil reference standards, including the active pharmaceutical ingredient, its metabolites, and potential synthesis-related impurities, to perform rigorous quality control. These compounds are essential for accurate impurity profiling and the validation of analytical methods used to monitor the chemical stability of the drug. Additionally, stable isotope labelled compounds are utilized as internal standards in mass spectrometry to enhance quantification precision and account for matrix interference. By providing access to structurally characterized impurities and degradants, these reference materials support researchers in conducting thorough stability studies and meeting pharmacopeial specifications, ensuring the consistent quality and safety profile of pharmaceutical preparations throughout their development and lifecycle.